Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    September 2019
  1. SPIRO SG, Shah PL, Rintoul RC, George J, et al
    Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00581-2019.
    PubMed     Text format     Abstract available



  2. "Screening for lung cancer: time for large-scale screening by chest computed tomography." Dekel Shlomi, Ronny Ben-Avi, Gingy Ronen Balmor, Amir Onn and Nir Peled. Eur Respir J 2014; 44: 217-238.
    Eur Respir J. 2019;54.
    PubMed     Text format    


  3. SOLTANI A, Mahmood MQ, Reid DW, Walters EH, et al
    Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation.
    Eur Respir J. 2019;54.
    PubMed     Text format    


    August 2019
  4. OBERT M
    Are estimations of radiomic image markers dispensable due to recent deep learning findings?
    Eur Respir J. 2019;54.
    PubMed     Text format    


    July 2019
  5. DENG HY, Zhou Q
    Lobectomy should remain the first choice for treating early stage nonsmall cell lung cancer.
    Eur Respir J. 2019;54.
    PubMed     Text format    


  6. LU W, Sharma P, Eapen MS, Sohal SS, et al
    Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis.
    Eur Respir J. 2019;54.
    PubMed     Text format    


    June 2019
  7. SEIJO LM, Soriano JB, Peces-Barba G
    New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  8. BERZENJI L, Van Schil PE
    Surgery or stereotactic body radiotherapy for early-stage lung cancer: two sides of the same coin?
    Eur Respir J. 2019;53.
    PubMed     Text format    


  9. KRISTOF AS, Ortega VE
    The discovery of novel mechanisms for lymphangioleiomyomatosis pathogenesis through GWAS: a rarity in rare respiratory disorders.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  10. AMAT B, Sapia S
    A journey to the centre of the mediastinal lymph nodes.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    May 2019
  11. GRACIE K, Kennedy MPT, Esterbrook G, Smith G, et al
    The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening.
    Eur Respir J. 2019 May 16. pii: 13993003.02221-2018.
    PubMed     Text format    


    April 2019
  12. WIJMANS L, Yared J, de Bruin DM, Meijer SL, et al
    Needle-based confocal laser endomicroscopy (nCLE) for real-time diagnosing and staging of lung cancer.
    Eur Respir J. 2019 Apr 25. pii: 13993003.01520-2018.
    PubMed     Text format     Abstract available


  13. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.01257-2018.
    PubMed     Text format     Abstract available


    March 2019
  14. DETILLON DEMA, Aarts MJ, De Jaeger K, Van Eijck CHJ, et al
    Video-assisted thoracic lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer in elderly patients: a propensity matched comparative analysis.
    Eur Respir J. 2019 Mar 28. pii: 13993003.01561-2018.
    PubMed     Text format     Abstract available


    February 2019
  15. CASAL RF, Sepesi B, Sagar AS, Tschirren J, et al
    Centrally-located lung cancer and risk of occult nodal disease: an objective evaluation of multiple definitions of tumor centrality with a dedicated imaging software.
    Eur Respir J. 2019 Feb 28. pii: 13993003.02220-2018.
    PubMed     Text format     Abstract available


    January 2019
  16. SPENCER KL, Kennedy MPT, Lummis KL, Ellames DAB, et al
    Surgery or radiotherapy for stage I lung cancer? An intention to treat analysis.
    Eur Respir J. 2019 Jan 11. pii: 13993003.01568-2018.
    PubMed     Text format     Abstract available


  17. SHIN SH, Jeong DY, Lee KS, Cho JH, et al
    Which definition of central tumour is more predictive of occult mediastinal metastasis in non-small cell lung cancer patients with radiologic N0 disease?
    Eur Respir J. 2019 Jan 11. pii: 13993003.01508-2018.
    PubMed     Text format     Abstract available


    December 2018
  18. LU J, Zhong H, Chu T, Zhang X, et al
    Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for non-small cell lung cancer therapy.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01562-2018.
    PubMed     Text format     Abstract available


  19. CROMBAG LMM, Dooms C, Stigt JA, Tournoy KG, et al
    Systematic and combined endosonographic staging of lung cancer (SCORE Study).
    Eur Respir J. 2018 Dec 21. pii: 13993003.00800-2018.
    PubMed     Text format     Abstract available


    October 2018
  20. RICH AL, Baldwin DR, Beckett P, Berghmans T, et al
    ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe.
    Eur Respir J. 2018 Oct 25. pii: 13993003.00610-2018.
    PubMed     Text format     Abstract available


    September 2018
  21. MEYER G, Besse B, Doubre H, Charles-Nelson A, et al
    Antitumor Effect of Low Molecular Weight Heparin in Localised Lung Cancer A Phase III Clinical Trial.
    Eur Respir J. 2018 Sep 27. pii: 13993003.01220-2018.
    PubMed     Text format     Abstract available


    August 2018
  22. VISSER S, Huisbrink J, van 't Veer NE, van Toor JJ, et al
    Renal impairment during pemetrexed maintenance in patients with advanced non-small-cell lung cancer: a cohort study.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00884-2018.
    PubMed     Text format     Abstract available


  23. VOLLMER I, Sanchez M, Rami-Porta R
    Lung cancer staging: imagine fewer images.
    Eur Respir J. 2018;52.
    PubMed     Text format    


  24. TOURNOY KG, Van Meerbeeck JP
    Lung cancer staging: imagine fewer images.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    June 2018
  25. LOUBIERE S, Barlesi F, Missy P, Morin F, et al
    Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  26. UGUEN A
    Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  27. MASSARD G, Tabin N, Mitchell S, Batirel H, et al
    A harmonised European training syllabus for thoracic surgery: report from the ESTS/ERS task force group.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  28. KURMI OP
    Is low level of vitamin D a marker of poor health, or a cause?
    Eur Respir J. 2018;51.
    PubMed     Text format    


    May 2018
  29. MIKESCH JH, Schwammbach D, Hartmann W, Schmidt LH, et al
    Reptin drives tumour progression and resistance to chemotherapy in non-small cell lung cancer.
    Eur Respir J. 2018 May 31. pii: 13993003.01637-2017.
    PubMed     Text format     Abstract available


  30. SANDRI BJ, Kaplan A, Hodgson SW, Peterson M, et al
    Multi-Omic Molecular Profiling of Lung Cancer in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2018 May 24. pii: 13993003.02665-2017.
    PubMed     Text format     Abstract available


  31. SUN YQ, Brumpton BM, Bonilla C, Lewis SJ, et al
    Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study.
    Eur Respir J. 2018 May 10. pii: 13993003.00329-2018.
    PubMed     Text format     Abstract available


  32. SCHEERENS C, Beernaert K, Pype P, Cohen J, et al
    Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  33. VAN MEERBEECK JP, Jansen G, Giovannetti E, Peters GJ, et al
    Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    April 2018
  34. RAMI-PORTA R, Call S, Dooms C, Obiols C, et al
    Lung cancer staging: a concise update.
    Eur Respir J. 2018 Apr 26. pii: 13993003.00190-2018.
    PubMed     Text format     Abstract available


  35. DECALUWE H, Dooms C, De Leyn P, Thomas P, et al
    Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  36. ADDEO A, Banna G
    Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    March 2018
  37. ZUGAZAGOITIA J, Biosca M, Olivera J, Eugenia Olmedo M, et al
    Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small-cell lung cancer.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02431-2017.
    PubMed     Text format    


  38. LOUBIERE S, Drezet A, Beau-Faller M, Moro-Sibilot D, et al
    Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  39. UGUEN M, Dewitte JD, Lodde B, Marcorelles P, et al
    Asbestos-related lung cancers are rarely associated with ALK, ROS1 and RET rearrangements.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    December 2017
  40. DECALUWE H, Dooms C, D'Journo XB, Call S, et al
    Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    October 2017
  41. SUN YQ, Chen Y, Langhammer A, Skorpen F, et al
    Passive smoking in relation to lung cancer incidence and histologic types in Norwegian adults: the HUNT study.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  42. PARIS C, Do P, Mastroianni B, Dixmier A, et al
    Association between lung cancer somatic mutations and occupational exposure in never-smokers.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    August 2017
  43. TOMASINI P, Brosseau S, Mazieres J, Merlio JP, et al
    EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  44. GLATZER M, Rittmeyer A, Muller J, Opitz I, et al
    Treatment of limited disease small cell lung cancer: the multidisciplinary team.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  45. PLUVY J, Brosseau S, Naltet C, Opsomer MA, et al
    Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    May 2017
  46. AAMLI GAGNAT A, Gjerdevik M, Gallefoss F, Coxson HO, et al
    Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    April 2017
  47. TIAN Q, Deng WJ, Li ZW
    Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  48. KHIROYA H, Moore JS, Ahmad N, Kay J, et al
    IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  49. CALVAYRAC O, Pradines A, Pons E, Mazieres J, et al
    Molecular biomarkers for lung adenocarcinoma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    March 2017
  50. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  51. DE PERROT M, Dong Z, Bradbury P, Patsios D, et al
    Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: